QLT, Inc. (USA) (NASDAQ:QLTI)

CAPS Rating: 1 out of 5

A biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies.

Recs

1
Player Avatar BuffySoro (76.39) Submitted: 1/3/2009 10:57:26 AM : Outperform Start Price: $1.29 QLTI Score: +76.71

I picked this because of the favorable prospects of the industry, and this looks like a cheap diamond among expensive pebbles.

Featured Broker Partners


Advertisement